Fluorine in PDB 8b92: Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2)
Protein crystallography data
The structure of Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2), PDB code: 8b92
was solved by
A.Friberg,
D.L.Orsi,
E.Pook,
S.Siegel,
C.T.Lemke,
T.Stellfeld,
V.Puetter,
J.Goldstein,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.26 /
1.66
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
60.257,
85.698,
120.399,
90,
90,
90
|
R / Rfree (%)
|
19.5 /
22.7
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2)
(pdb code 8b92). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2), PDB code: 8b92:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 8b92
Go back to
Fluorine Binding Sites List in 8b92
Fluorine binding site 1 out
of 4 in the Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:29.9
occ:1.00
|
F8
|
A:Q5X501
|
0.0
|
29.9
|
1.0
|
C7
|
A:Q5X501
|
1.3
|
24.7
|
1.0
|
C9
|
A:Q5X501
|
2.3
|
23.2
|
1.0
|
C6
|
A:Q5X501
|
2.4
|
26.5
|
1.0
|
N5
|
A:Q5X501
|
2.8
|
24.6
|
1.0
|
CA
|
A:SER289
|
3.1
|
24.9
|
1.0
|
C4
|
A:Q5X501
|
3.1
|
27.9
|
1.0
|
O17
|
A:Q5X501
|
3.2
|
30.0
|
1.0
|
CG2
|
A:ILE326
|
3.2
|
23.4
|
1.0
|
CB
|
A:SER289
|
3.3
|
26.0
|
1.0
|
CD1
|
A:ILE326
|
3.4
|
22.3
|
1.0
|
C16
|
A:Q5X501
|
3.6
|
27.6
|
1.0
|
C10
|
A:Q5X501
|
3.6
|
27.0
|
1.0
|
CG1
|
A:ILE326
|
3.7
|
21.6
|
1.0
|
N
|
A:SER289
|
3.7
|
23.1
|
1.0
|
CB
|
A:ALA292
|
3.9
|
21.8
|
1.0
|
CB
|
A:ILE326
|
4.1
|
20.4
|
1.0
|
C15
|
A:Q5X501
|
4.1
|
26.2
|
1.0
|
C3
|
A:Q5X501
|
4.2
|
27.3
|
1.0
|
C
|
A:ARG288
|
4.3
|
23.7
|
1.0
|
C18
|
A:Q5X501
|
4.3
|
32.6
|
1.0
|
O
|
A:ARG288
|
4.3
|
26.2
|
1.0
|
C
|
A:SER289
|
4.3
|
27.1
|
1.0
|
O
|
A:SER289
|
4.5
|
23.3
|
1.0
|
OG
|
A:SER289
|
4.7
|
27.0
|
1.0
|
O
|
A:CYS285
|
4.8
|
28.5
|
1.0
|
C11
|
A:Q5X501
|
4.9
|
29.3
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 8b92
Go back to
Fluorine Binding Sites List in 8b92
Fluorine binding site 2 out
of 4 in the Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:34.8
occ:1.00
|
F33
|
A:Q5X501
|
0.0
|
34.8
|
1.0
|
C32
|
A:Q5X501
|
1.3
|
33.8
|
1.0
|
C34
|
A:Q5X501
|
2.3
|
28.2
|
1.0
|
C19
|
A:Q5X501
|
2.4
|
29.6
|
1.0
|
CZ
|
A:PHE282
|
2.9
|
41.5
|
1.0
|
N21
|
A:Q5X501
|
2.9
|
33.0
|
1.0
|
C20
|
A:Q5X501
|
2.9
|
32.9
|
1.0
|
OE1
|
A:GLN286
|
3.1
|
37.4
|
1.0
|
CE1
|
A:PHE282
|
3.3
|
40.7
|
1.0
|
CE2
|
A:PHE282
|
3.6
|
44.2
|
1.0
|
C2
|
A:Q5X501
|
3.6
|
29.8
|
1.0
|
C18
|
A:Q5X501
|
3.6
|
32.6
|
1.0
|
CD2
|
A:LEU453
|
3.7
|
36.2
|
1.0
|
O31
|
A:Q5X501
|
4.0
|
29.3
|
1.0
|
CB
|
A:GLN286
|
4.0
|
29.4
|
1.0
|
C3
|
A:Q5X501
|
4.1
|
27.3
|
1.0
|
C22
|
A:Q5X501
|
4.1
|
31.7
|
1.0
|
CA
|
A:GLN286
|
4.1
|
29.3
|
1.0
|
CD
|
A:GLN286
|
4.2
|
37.5
|
1.0
|
CZ
|
A:PHE363
|
4.2
|
35.5
|
1.0
|
CD1
|
A:PHE282
|
4.3
|
41.0
|
1.0
|
N
|
A:GLN286
|
4.4
|
31.2
|
1.0
|
CD2
|
A:PHE282
|
4.5
|
41.6
|
1.0
|
CG
|
A:GLN286
|
4.7
|
33.2
|
1.0
|
O
|
A:PHE282
|
4.7
|
33.2
|
1.0
|
CG
|
A:PHE282
|
4.9
|
39.0
|
1.0
|
CE2
|
A:PHE363
|
4.9
|
38.6
|
1.0
|
CE1
|
A:PHE363
|
4.9
|
35.8
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 8b92
Go back to
Fluorine Binding Sites List in 8b92
Fluorine binding site 3 out
of 4 in the Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F501
b:48.6
occ:1.00
|
F8
|
B:Q5X501
|
0.0
|
48.6
|
1.0
|
C7
|
B:Q5X501
|
1.3
|
38.9
|
1.0
|
C6
|
B:Q5X501
|
2.4
|
38.8
|
1.0
|
C9
|
B:Q5X501
|
2.4
|
45.0
|
1.0
|
N5
|
B:Q5X501
|
2.7
|
32.7
|
1.0
|
C4
|
B:Q5X501
|
3.0
|
31.7
|
1.0
|
O17
|
B:Q5X501
|
3.0
|
33.9
|
1.0
|
CG2
|
B:ILE326
|
3.1
|
22.2
|
1.0
|
CA
|
B:SER289
|
3.3
|
27.8
|
1.0
|
CB
|
B:SER289
|
3.4
|
26.1
|
1.0
|
CD1
|
B:ILE326
|
3.5
|
21.6
|
1.0
|
C16
|
B:Q5X501
|
3.6
|
45.6
|
1.0
|
C10
|
B:Q5X501
|
3.7
|
44.7
|
1.0
|
CG1
|
B:ILE326
|
3.9
|
22.6
|
1.0
|
N
|
B:SER289
|
4.0
|
29.8
|
1.0
|
CB
|
B:ILE326
|
4.0
|
20.2
|
1.0
|
C3
|
B:Q5X501
|
4.1
|
27.3
|
1.0
|
CB
|
B:ALA292
|
4.1
|
27.4
|
1.0
|
C15
|
B:Q5X501
|
4.1
|
44.2
|
1.0
|
C18
|
B:Q5X501
|
4.2
|
30.3
|
1.0
|
C
|
B:ARG288
|
4.5
|
30.6
|
1.0
|
O
|
B:ARG288
|
4.5
|
29.9
|
1.0
|
C
|
B:SER289
|
4.6
|
27.2
|
1.0
|
O
|
B:SER289
|
4.7
|
27.5
|
1.0
|
OG
|
B:SER289
|
4.8
|
29.1
|
1.0
|
C11
|
B:Q5X501
|
4.9
|
50.0
|
1.0
|
O
|
B:CYS285
|
4.9
|
28.2
|
1.0
|
OH
|
B:TYR327
|
5.0
|
28.9
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 8b92
Go back to
Fluorine Binding Sites List in 8b92
Fluorine binding site 4 out
of 4 in the Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Pparg and NCOR2 with An Inverse Agonist (Compound Si-2) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F501
b:30.0
occ:1.00
|
F33
|
B:Q5X501
|
0.0
|
30.0
|
1.0
|
C32
|
B:Q5X501
|
1.4
|
29.8
|
1.0
|
C19
|
B:Q5X501
|
2.4
|
27.6
|
1.0
|
C34
|
B:Q5X501
|
2.4
|
29.4
|
1.0
|
OE1
|
B:GLN286
|
2.6
|
41.2
|
1.0
|
N21
|
B:Q5X501
|
2.7
|
28.6
|
1.0
|
C20
|
B:Q5X501
|
2.8
|
28.4
|
1.0
|
O
|
B:HOH650
|
3.2
|
61.4
|
1.0
|
CZ
|
B:PHE282
|
3.4
|
34.3
|
1.0
|
CE1
|
B:PHE282
|
3.5
|
32.9
|
1.0
|
CD2
|
B:LEU453
|
3.6
|
29.4
|
1.0
|
C18
|
B:Q5X501
|
3.7
|
30.3
|
1.0
|
C2
|
B:Q5X501
|
3.7
|
28.4
|
1.0
|
CD
|
B:GLN286
|
3.8
|
40.5
|
1.0
|
O31
|
B:Q5X501
|
3.9
|
28.0
|
1.0
|
C22
|
B:Q5X501
|
3.9
|
29.0
|
1.0
|
CB
|
B:GLN286
|
4.1
|
32.0
|
1.0
|
C3
|
B:Q5X501
|
4.1
|
27.3
|
1.0
|
CA
|
B:GLN286
|
4.2
|
31.6
|
1.0
|
CE2
|
B:PHE282
|
4.2
|
35.7
|
1.0
|
CZ
|
B:PHE363
|
4.3
|
38.5
|
1.0
|
CD1
|
B:PHE282
|
4.5
|
32.8
|
1.0
|
CG
|
B:GLN286
|
4.5
|
35.4
|
1.0
|
N
|
B:GLN286
|
4.6
|
31.3
|
1.0
|
NE2
|
B:GLN286
|
4.8
|
42.2
|
1.0
|
C23
|
B:Q5X501
|
4.9
|
33.1
|
1.0
|
O
|
B:PHE282
|
4.9
|
28.6
|
1.0
|
CG
|
B:LEU453
|
5.0
|
30.0
|
1.0
|
CE2
|
B:PHE363
|
5.0
|
40.5
|
1.0
|
|
Reference:
D.L.Orsi,
S.J.Ferrara,
S.Siegel,
A.Friberg,
L.Bouche,
E.Pook,
P.Lienau,
J.P.Bluck,
C.T.Lemke,
G.Akcay,
T.Stellfeld,
H.Meyer,
V.Putter,
S.J.Holton,
D.Korr,
I.Jerchel-Furau,
C.Pantelidou,
C.A.Strathdee,
M.Meyerson,
K.Eis,
J.T.Goldstein.
Discovery and Characterization of Orally Bioavailable 4-Chloro-6-Fluoroisophthalamides As Covalent Pparg Inverse-Agonists. Bioorg.Med.Chem. V. 78 17130 2022.
ISSN: ESSN 1464-3391
PubMed: 36542958
DOI: 10.1016/J.BMC.2022.117130
Page generated: Fri Aug 2 16:45:05 2024
|